{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:59:50Z","timestamp":1780574390137,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P2GEP3_178155"],"award-info":[{"award-number":["P2GEP3_178155"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.vaccine.2020.11.045","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T02:41:49Z","timestamp":1608864109000},"page":"652-657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Gu\u00e9rin (BCG) vaccine"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-4574","authenticated-orcid":false,"given":"Laure F.","family":"Pittet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Tebruegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Donath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8404-4462","authenticated-orcid":false,"given":"Nicole","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Casalaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warwick J.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-7884","authenticated-orcid":false,"given":"Roy","family":"Robins-Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-1685","authenticated-orcid":false,"given":"Nicole","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.11.045_b0005","series-title":"Buruli ulcer \u2013 Mycobacterium ulcerans disease","author":"Pluschke","year":"2019"},{"key":"10.1016\/j.vaccine.2020.11.045_b0010","first-page":"73","article-title":"BCG vaccines: WHO position paper - February 2018","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2020.11.045_b0015","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02612-17","article-title":"Comparative genomics shows that Mycobacterium ulcerans migration and expansion preceded the rise of Buruli Ulcer in Southeastern Australia","volume":"84","author":"Buultjens","year":"2018","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2020.11.045_b0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tube.2009.03.002","article-title":"Mapping the global use of different BCG vaccine strains","volume":"89","author":"Ritz","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.vaccine.2020.11.045_b0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2020.11.045_b0030","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1038\/srep15443","article-title":"Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations","volume":"5","author":"Abdallah","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.11.045_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial","volume":"185","author":"Ritz","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2020.11.045_b0040","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.vaccine.2019.11.060","article-title":"Licensed Bacille Calmette-Guerin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation","volume":"38","author":"Angelidou","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.045_b0045","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/jiy207","article-title":"Does BCG vaccination protect against nontuberculous mycobacterial infection? A systematic review and meta-analysis","volume":"218","author":"Zimmermann","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.045_b0050","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.vaccine.2013.03.059","article-title":"Non-specific effect of Bacille Calmette-Guerin vaccine on the immune response to routine immunisations","volume":"31","author":"Ritz","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.045_b0055","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.vaccine.2019.03.016","article-title":"The influence of neonatal Bacille Calmette-Guerin (BCG) immunisation on heterologous vaccine responses in infants","volume":"37","author":"Zimmermann","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.045_b0060","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/archdischild-2015-310282","article-title":"Non-specific effects of vaccines: plausible and potentially important, but implications uncertain","volume":"102","author":"Pollard","year":"2017","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2020.11.045_b0065","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0035-9203(76)90128-0","article-title":"The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda","volume":"70","author":"Smith","year":"1976","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2020.11.045_b0070","first-page":"111","article-title":"BCG vaccination against Mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda","author":"Bradley","year":"1969","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.11.045_b0075","first-page":"1389","article-title":"Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer)","volume":"9","author":"Portaels","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2020.11.045_b0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.72.1.62-65.2004","article-title":"Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease","volume":"72","author":"Portaels","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.045_b0085","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/ciu584","article-title":"Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection","volume":"59","author":"Pommelet","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.045_b0090","first-page":"536","article-title":"Risk factors for Buruli ulcer in C\u00f4te d\u2019Ivoire: results of a case-control study, August 2001","volume":"8","author":"Ahoua","year":"2009","journal-title":"Afr J Biotechnol"},{"key":"10.1016\/j.vaccine.2020.11.045_b0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2249.2007.03506.x","article-title":"Systemic and local interferon-gamma production following Mycobacterium ulcerans infection","volume":"150","author":"Schipper","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2020.11.045_b0100","doi-asserted-by":"crossref","unstructured":"Nackers F, Dramaix M, Johnson RC, Zinsou C, Robert A, E DEBB, et al. BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg. 2006;75:768-74, https:\/\/pubmed.ncbi.nlm.nih.gov\/17038709\/.","DOI":"10.4269\/ajtmh.2006.75.768"},{"key":"10.1016\/j.vaccine.2020.11.045_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005415","article-title":"Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression","volume":"11","author":"Nausch","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2020.11.045_b0110","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1086\/429623","article-title":"Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana","volume":"40","author":"Raghunathan","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.045_b0115","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3201\/eid1209.050598","article-title":"Risk factors for Buruli ulcer","volume":"12","author":"Debacker","year":"2006","journal-title":"Benin Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.045_b0120","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.vaccine.2016.06.077","article-title":"Comparable CD4 and CD8 T cell responses and cytokine release after at-birth and delayed BCG immunisation in infants born in Australia","volume":"34","author":"Ritz","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.045_b0125","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1128\/IAI.01622-06","article-title":"A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice","volume":"75","author":"Tanghe","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.045_b0130","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","article-title":"Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.045_b0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000985","article-title":"BCG-mediated protection against Mycobacterium ulcerans infection in the mouse","volume":"5","author":"Converse","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2020.11.045_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003457","article-title":"Effectiveness of routine BCG vaccination on Buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo","volume":"9","author":"Phillips","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2020.11.045_b0145","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1038\/s41598-018-26425-1","article-title":"Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic","volume":"8","author":"Nakanaga","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.11.045_b0150","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.283.5403.854","article-title":"Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence","volume":"283","author":"George","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2020.11.045_b0155","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1084\/jem.20160662","article-title":"Mycolactone subverts immunity by selectively blocking the Sec61 translocon","volume":"213","author":"Baron","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.11.045_b0160","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1086\/646615","article-title":"Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with Buruli ulcer disease","volume":"200","author":"Phillips","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.045_b0165","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/IAI.69.3.1704-1707.2001","article-title":"Immune response to infection with Mycobacterium ulcerans","volume":"69","author":"Gooding","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.045_b0170","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1128\/IAI.70.10.5562-5567.2002","article-title":"Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts","volume":"70","author":"Gooding","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.11.045_b0175","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/368315","article-title":"Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans","volume":"36","author":"Gooding","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.11.045_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033600","article-title":"Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage","volume":"7","author":"Marion","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.11.045_b0185","series-title":"Mycolactone production in Mycobacterium tuberculosis complex species","author":"Keller","year":"2017"},{"key":"10.1016\/j.vaccine.2020.11.045_b0190","article-title":"Mycobacterial species as case-study of comparative genome analysis","author":"Zakham","year":"2011","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2020.11.045_b0195","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1016\/j.vaccine.2015.06.097","article-title":"Current status of Bacille Calmette Guerin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines","volume":"33","author":"Dierig","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.11.045_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032567","article-title":"Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guerin (BCG) vaccines from different sources Kazakhstan","volume":"7","author":"Favorov","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.11.045_b0205","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fimmu.2017.01262","article-title":"Polyfunctional CD4(+) T cells as targets for tuberculosis vaccination","volume":"8","author":"Lewinsohn","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.11.045_b0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.11.045_bib211","first-page":"57","article-title":"Bacille Calmette-Gu\u00e9rin (BCG) and new TB vaccines: specific, cross-mycobacterial and off-target effects","volume":"36","author":"Fritschi","year":"2020","journal-title":"Paediatr Respir Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20314985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:52:25Z","timestamp":1759402345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20314985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0264410X20314985"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Gu\u00e9rin (BCG) vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.11.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}